Intensity Therapeutics, Inc. INTS
Regular-session close
After hours · Nov 20, 4:01 PM ET
- YTD
- -75.80%
- 1 year
- -73.89%
INTS free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-9,233,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | -9,233,000 | 5,987,000 | Not meaningful |
| FY 2024 | 2024-12-31 | -15,220,000 | -8,015,000 | Not meaningful |
| FY 2023 | 2023-12-31 | -7,205,000 | -1,728,000 | Not meaningful |
| FY 2022 | 2022-12-31 | -5,477,000 | 1,349,863 | Not meaningful |
| FY 2021 | 2021-12-31 | -6,826,863 | -1,456,671 | Not meaningful |
| FY 2020 | 2020-12-31 | -5,370,192 | -953,847 | Not meaningful |
| FY 2019 | 2019-12-31 | -4,416,345 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:42:44.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
